Diseases /
Malignant Supratentorial Neoplasm
Back to Diseases List
Associated Genetic Biomarkers
Overview
Malignant supratentorial neoplasms most frequently harbor alterations in EPHB1, DICER1, CDK12, ATR, and ATM [2].
EPHB1 V205E, EPHB1 Mutation, CDK12 P1091S, CDK12 Mutation, and ATR Mutation are the most common alterations in malignant supratentorial neoplasm [2].
Clinical Trials
Significant Genes in Malignant Supratentorial Neoplasm
Disease Details
References
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.
3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.